Fail Safe Cell Therapy


The advent of human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells had a paradigm-shifting effect on regenerative medicine

a powerful new treatment against diseases underlined by cell loss, tissue degeneration and aging.
With these applications came critical and important challenges:

uncontrolled proliferation and genetic mutations
in therapeutic cells that pose safety risks to patients.
panCELLa has developed a solution to these challenges.

Quantifying & Mitigating the Risk

Engineering cells to give us total control over their fate:

The solution to safe cell therapies

The FailSafe Cell System

FailSafe Cells use cell division loci to control cell proliferation (Continue Reading)

panCELLa technology allows one to provide a precise definition of safety and to quantify the safety level of a prospective cell therapy. The integration of the FailSafe Cell System in cell therapies will be critical for regulators, clinicians and patients to make informed decisions.   To make your cell therapy a FailSafe Cell Therapy, contact panCELLa today

You are Contacting our Executive Management

Your Details

Let us know how to get back to you.

How can we help?

Feel free to ask a question or simply leave a comment.